Epizyme (EPZM) Misses Q3 EPS by 3c

Epizyme (NASDAQ: EPZM) reported Q3 EPS of ($0.58), $0.03 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7 million.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• USCB Financial Holdings, Inc. (USCB) Tops Q1 EPS by 2c
• SPS Commerce (SPSC) Tops Q1 EPS by 12c